To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Intra-individual stabilit… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years

Journal article
Authors Henrik Zetterberg
Mona Pedersen
Karin Lind
Maria Svensson
Sindre Rolstad
Carl Eckerström
Steinar Syversen
Ulla-Britt Mattsson
Christina Ysander
Niklas Mattsson
Arto Nordlund
Hugo Vanderstichele
Eugeen Vanmechelen
Michael Jonsson
Åke Edman
Kaj Blennow
Anders Wallin
Published in Journal of Alzheimer's disease : JAD
Volume 12
Issue 3
Pages 255-60
ISSN 1387-2877
Publication year 2007
Published at Institute of Neuroscience and Physiology
Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Pages 255-60
Language en
Links www.ncbi.nlm.nih.gov/entrez/query.f...
Keywords Aged, Alzheimer Disease, cerebrospinal fluid, epidemiology, Amyloid beta-Protein, cerebrospinal fluid, Biological Markers, Cognition Disorders, diagnosis, epidemiology, Disease Progression, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Severity of Illness Index, Time Factors, tau Proteins, cerebrospinal fluid
Subject categories Medical and Health Sciences

Abstract

This study examines the intra-individual stability of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) over 2 years in 83 patients with mild cognitive impairment (MCI) and 17 cognitively healthy control individuals. All participants underwent clinical and neuropsychological evaluation and lumbar puncture at baseline and after 2 years at a university hospital memory clinic. CSF was analyzed for total tau (T-tau), phospho-tau(181) (P-tau(181)) and amyloid-beta(1-42) (Abeta(1-42)). During the 2-year observational time, 12 MCI patients progressed to AD and 3 progressed to vascular dementia, while 68 remained stable. Baseline T-tau and P-tau(181) levels were elevated in the MCI-AD group as compared to the stable MCI patients and the control group (p<0.01), while baseline Abeta(1-42) levels were lower (p<0.001). Stable MCI patients were biochemically indistinguishable from controls. The biomarker levels at baseline and after 2 years showed Pearson R values between 0.81 and 0.91 (p<0.001) and coefficients of variation of 7.2 to 8.7%. In conclusion, intra-individual biomarker levels are remarkably stable over 2 years. Thus, even minor biochemical changes induced by treatment against AD should be detectable using these biomarkers, which bodes well for their usefulness as surrogate markers for drug efficacy in clinical trials.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?